サンプルお申込み

お問い合わせ

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、非オピオイド系鎮痛剤パッチの世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に非オピオイド系鎮痛剤パッチ市場を分類しています。
本レポートでは世界の非オピオイド系鎮痛剤パッチ市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：GlaxoSmithKline Plc、Pfizer, Inc.、Teikoku Seiyaku Co., Ltd.、Mylan N.V.、Hisamitsu Pharmaceutical Co.,Inc、Acorda Therapeutics, Inc、Endo International plc、Allergan、Teh Seng Pharmaceutical Mfg、IBSA Institut Biochimque SA

レポートは非オピオイド系鎮痛剤パッチの主要生産者を調査し、主要地域や国の消費状況も提供します。非オピオイド系鎮痛剤パッチの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Lidocaine Patches
    Diclofenac Patches
    Methyl Salicylate Patches
    Capsaicin Patches
    Ketoprofen Patches
    Others

用途別の市場セグメント：
    Hospital Pharmacies
    Online Pharmacies
    Independent Pharmacies & Drug Stores

本レポートの詳細内容
本レポートは、世界の非オピオイド系鎮痛剤パッチ市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて非オピオイド系鎮痛剤パッチ市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）の非オピオイド系鎮痛剤パッチ生産量、成長率、市場シェアを調査している。

二. 消費面では、非オピオイド系鎮痛剤パッチの売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーの非オピオイド系鎮痛剤パッチ売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の非オピオイド系鎮痛剤パッチ市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本非オピオイド系鎮痛剤パッチのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：非オピオイド系鎮痛剤パッチのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： 非オピオイド系鎮痛剤パッチの世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおける非オピオイド系鎮痛剤パッチの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章非オピオイド系鎮痛剤パッチメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：非オピオイド系鎮痛剤パッチの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：非オピオイド系鎮痛剤パッチの主要メーカーの概要を提供し、製品の説明と仕様、非オピオイド系鎮痛剤パッチの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：非オピオイド系鎮痛剤パッチの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

The global Non-opioid Analgesic Patch market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Non-opioid Analgesic Patch is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Non-opioid Analgesic Patch is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Non-opioid Analgesic Patch is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of Non-opioid Analgesic Patch include GlaxoSmithKline Plc, Pfizer, Inc., Teikoku Seiyaku Co., Ltd., Mylan N.V., Hisamitsu Pharmaceutical Co.,Inc, Acorda Therapeutics, Inc, Endo International plc, Allergan and Teh Seng Pharmaceutical Mfg, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Non-opioid Analgesic Patch, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Non-opioid Analgesic Patch, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Non-opioid Analgesic Patch, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Non-opioid Analgesic Patch sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Non-opioid Analgesic Patch market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Non-opioid Analgesic Patch sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including GlaxoSmithKline Plc, Pfizer, Inc., Teikoku Seiyaku Co., Ltd., Mylan N.V., Hisamitsu Pharmaceutical Co.,Inc, Acorda Therapeutics, Inc, Endo International plc, Allergan and Teh Seng Pharmaceutical Mfg, etc.
Market Segmentation
By Company
    GlaxoSmithKline Plc
    Pfizer, Inc.
    Teikoku Seiyaku Co., Ltd.
    Mylan N.V.
    Hisamitsu Pharmaceutical Co.,Inc
    Acorda Therapeutics, Inc
    Endo International plc
    Allergan
    Teh Seng Pharmaceutical Mfg
    IBSA Institut Biochimque SA

Segment by Type
    Lidocaine Patches
    Diclofenac Patches
    Methyl Salicylate Patches
    Capsaicin Patches
    Ketoprofen Patches
    Others

Segment by Application
    Hospital Pharmacies
    Online Pharmacies
    Independent Pharmacies & Drug Stores

Segment by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Non-opioid Analgesic Patch in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Non-opioid Analgesic Patch manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-opioid Analgesic Patch sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
    Table 1. Global Non-opioid Analgesic Patch Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Lidocaine Patches
    Table 3. Major Manufacturers of Diclofenac Patches
    Table 4. Major Manufacturers of Methyl Salicylate Patches
    Table 5. Major Manufacturers of Capsaicin Patches
    Table 6. Major Manufacturers of Ketoprofen Patches
    Table 7. Major Manufacturers of Others
    Table 8. Global Non-opioid Analgesic Patch Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 9. Global Non-opioid Analgesic Patch Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 10. Global Non-opioid Analgesic Patch Revenue by Region (2019-2024) & (US$ Million)
    Table 11. Global Non-opioid Analgesic Patch Revenue by Region (2025-2030) & (US$ Million)
    Table 12. Global Non-opioid Analgesic Patch Revenue Market Share by Region (2019-2024)
    Table 13. Global Non-opioid Analgesic Patch Revenue Market Share by Region (2025-2030)
    Table 14. Global Non-opioid Analgesic Patch Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 15. Global Non-opioid Analgesic Patch Sales by Region (2019-2024) & (K Units)
    Table 16. Global Non-opioid Analgesic Patch Sales by Region (2025-2030) & (K Units)
    Table 17. Global Non-opioid Analgesic Patch Sales Market Share by Region (2019-2024)
    Table 18. Global Non-opioid Analgesic Patch Sales Market Share by Region (2025-2030)
    Table 19. Global Non-opioid Analgesic Patch Sales by Manufacturers (2019-2024) & (K Units)
    Table 20. Global Non-opioid Analgesic Patch Sales Share by Manufacturers (2019-2024)
    Table 21. Global Non-opioid Analgesic Patch Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 22. Global Non-opioid Analgesic Patch Revenue Share by Manufacturers (2019-2024)
    Table 23. Global Key Players of Non-opioid Analgesic Patch, Industry Ranking, 2022 VS 2023 VS 2024
    Table 24. Non-opioid Analgesic Patch Price by Manufacturers 2019-2024 (USD/Unit)
    Table 25. Global Non-opioid Analgesic Patch Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 26. Global Non-opioid Analgesic Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-opioid Analgesic Patch as of 2023)
    Table 27. Global Key Manufacturers of Non-opioid Analgesic Patch, Manufacturing Base Distribution and Headquarters
    Table 28. Global Key Manufacturers of Non-opioid Analgesic Patch, Product Offered and Application
    Table 29. Global Key Manufacturers of Non-opioid Analgesic Patch, Date of Enter into This Industry
    Table 30. Mergers & Acquisitions, Expansion Plans
    Table 31. Global Non-opioid Analgesic Patch Sales by Type (2019-2024) & (K Units)
    Table 32. Global Non-opioid Analgesic Patch Sales by Type (2025-2030) & (K Units)
    Table 33. Global Non-opioid Analgesic Patch Sales Share by Type (2019-2024)
    Table 34. Global Non-opioid Analgesic Patch Sales Share by Type (2025-2030)
    Table 35. Global Non-opioid Analgesic Patch Revenue by Type (2019-2024) & (US$ Million)
    Table 36. Global Non-opioid Analgesic Patch Revenue by Type (2025-2030) & (US$ Million)
    Table 37. Global Non-opioid Analgesic Patch Revenue Share by Type (2019-2024)
    Table 38. Global Non-opioid Analgesic Patch Revenue Share by Type (2025-2030)
    Table 39. Non-opioid Analgesic Patch Price by Type (2019-2024) & (USD/Unit)
    Table 40. Global Non-opioid Analgesic Patch Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 41. Global Non-opioid Analgesic Patch Sales by Application (2019-2024) & (K Units)
    Table 42. Global Non-opioid Analgesic Patch Sales by Application (2025-2030) & (K Units)
    Table 43. Global Non-opioid Analgesic Patch Sales Share by Application (2019-2024)
    Table 44. Global Non-opioid Analgesic Patch Sales Share by Application (2025-2030)
    Table 45. Global Non-opioid Analgesic Patch Revenue by Application (2019-2024) & (US$ Million)
    Table 46. Global Non-opioid Analgesic Patch Revenue by Application (2025-2030) & (US$ Million)
    Table 47. Global Non-opioid Analgesic Patch Revenue Share by Application (2019-2024)
    Table 48. Global Non-opioid Analgesic Patch Revenue Share by Application (2025-2030)
    Table 49. Non-opioid Analgesic Patch Price by Application (2019-2024) & (USD/Unit)
    Table 50. Global Non-opioid Analgesic Patch Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 51. US & Canada Non-opioid Analgesic Patch Sales by Type (2019-2024) & (K Units)
    Table 52. US & Canada Non-opioid Analgesic Patch Sales by Type (2025-2030) & (K Units)
    Table 53. US & Canada Non-opioid Analgesic Patch Revenue by Type (2019-2024) & (US$ Million)
    Table 54. US & Canada Non-opioid Analgesic Patch Revenue by Type (2025-2030) & (US$ Million)
    Table 55. US & Canada Non-opioid Analgesic Patch Sales by Application (2019-2024) & (K Units)
    Table 56. US & Canada Non-opioid Analgesic Patch Sales by Application (2025-2030) & (K Units)
    Table 57. US & Canada Non-opioid Analgesic Patch Revenue by Application (2019-2024) & (US$ Million)
    Table 58. US & Canada Non-opioid Analgesic Patch Revenue by Application (2025-2030) & (US$ Million)
    Table 59. US & Canada Non-opioid Analgesic Patch Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 60. US & Canada Non-opioid Analgesic Patch Revenue by Country (2019-2024) & (US$ Million)
    Table 61. US & Canada Non-opioid Analgesic Patch Revenue by Country (2025-2030) & (US$ Million)
    Table 62. US & Canada Non-opioid Analgesic Patch Sales by Country (2019-2024) & (K Units)
    Table 63. US & Canada Non-opioid Analgesic Patch Sales by Country (2025-2030) & (K Units)
    Table 64. Europe Non-opioid Analgesic Patch Sales by Type (2019-2024) & (K Units)
    Table 65. Europe Non-opioid Analgesic Patch Sales by Type (2025-2030) & (K Units)
    Table 66. Europe Non-opioid Analgesic Patch Revenue by Type (2019-2024) & (US$ Million)
    Table 67. Europe Non-opioid Analgesic Patch Revenue by Type (2025-2030) & (US$ Million)
    Table 68. Europe Non-opioid Analgesic Patch Sales by Application (2019-2024) & (K Units)
    Table 69. Europe Non-opioid Analgesic Patch Sales by Application (2025-2030) & (K Units)
    Table 70. Europe Non-opioid Analgesic Patch Revenue by Application (2019-2024) & (US$ Million)
    Table 71. Europe Non-opioid Analgesic Patch Revenue by Application (2025-2030) & (US$ Million)
    Table 72. Europe Non-opioid Analgesic Patch Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 73. Europe Non-opioid Analgesic Patch Revenue by Country (2019-2024) & (US$ Million)
    Table 74. Europe Non-opioid Analgesic Patch Revenue by Country (2025-2030) & (US$ Million)
    Table 75. Europe Non-opioid Analgesic Patch Sales by Country (2019-2024) & (K Units)
    Table 76. Europe Non-opioid Analgesic Patch Sales by Country (2025-2030) & (K Units)
    Table 77. China Non-opioid Analgesic Patch Sales by Type (2019-2024) & (K Units)
    Table 78. China Non-opioid Analgesic Patch Sales by Type (2025-2030) & (K Units)
    Table 79. China Non-opioid Analgesic Patch Revenue by Type (2019-2024) & (US$ Million)
    Table 80. China Non-opioid Analgesic Patch Revenue by Type (2025-2030) & (US$ Million)
    Table 81. China Non-opioid Analgesic Patch Sales by Application (2019-2024) & (K Units)
    Table 82. China Non-opioid Analgesic Patch Sales by Application (2025-2030) & (K Units)
    Table 83. China Non-opioid Analgesic Patch Revenue by Application (2019-2024) & (US$ Million)
    Table 84. China Non-opioid Analgesic Patch Revenue by Application (2025-2030) & (US$ Million)
    Table 85. Asia Non-opioid Analgesic Patch Sales by Type (2019-2024) & (K Units)
    Table 86. Asia Non-opioid Analgesic Patch Sales by Type (2025-2030) & (K Units)
    Table 87. Asia Non-opioid Analgesic Patch Revenue by Type (2019-2024) & (US$ Million)
    Table 88. Asia Non-opioid Analgesic Patch Revenue by Type (2025-2030) & (US$ Million)
    Table 89. Asia Non-opioid Analgesic Patch Sales by Application (2019-2024) & (K Units)
    Table 90. Asia Non-opioid Analgesic Patch Sales by Application (2025-2030) & (K Units)
    Table 91. Asia Non-opioid Analgesic Patch Revenue by Application (2019-2024) & (US$ Million)
    Table 92. Asia Non-opioid Analgesic Patch Revenue by Application (2025-2030) & (US$ Million)
    Table 93. Asia Non-opioid Analgesic Patch Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 94. Asia Non-opioid Analgesic Patch Revenue by Region (2019-2024) & (US$ Million)
    Table 95. Asia Non-opioid Analgesic Patch Revenue by Region (2025-2030) & (US$ Million)
    Table 96. Asia Non-opioid Analgesic Patch Sales by Region (2019-2024) & (K Units)
    Table 97. Asia Non-opioid Analgesic Patch Sales by Region (2025-2030) & (K Units)
    Table 98. Middle East, Africa and Latin America Non-opioid Analgesic Patch Sales by Type (2019-2024) & (K Units)
    Table 99. Middle East, Africa and Latin America Non-opioid Analgesic Patch Sales by Type (2025-2030) & (K Units)
    Table 100. Middle East, Africa and Latin America Non-opioid Analgesic Patch Revenue by Type (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Non-opioid Analgesic Patch Revenue by Type (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Non-opioid Analgesic Patch Sales by Application (2019-2024) & (K Units)
    Table 103. Middle East, Africa and Latin America Non-opioid Analgesic Patch Sales by Application (2025-2030) & (K Units)
    Table 104. Middle East, Africa and Latin America Non-opioid Analgesic Patch Revenue by Application (2019-2024) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Non-opioid Analgesic Patch Revenue by Application (2025-2030) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Non-opioid Analgesic Patch Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 107. Middle East, Africa and Latin America Non-opioid Analgesic Patch Revenue by Country (2019-2024) & (US$ Million)
    Table 108. Middle East, Africa and Latin America Non-opioid Analgesic Patch Revenue by Country (2025-2030) & (US$ Million)
    Table 109. Middle East, Africa and Latin America Non-opioid Analgesic Patch Sales by Country (2019-2024) & (K Units)
    Table 110. Middle East, Africa and Latin America Non-opioid Analgesic Patch Sales by Country (2025-2030) & (K Units)
    Table 111. GlaxoSmithKline Plc Company Information
    Table 112. GlaxoSmithKline Plc Description and Major Businesses
    Table 113. GlaxoSmithKline Plc Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 114. GlaxoSmithKline Plc Non-opioid Analgesic Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. GlaxoSmithKline Plc Recent Developments
    Table 116. Pfizer, Inc. Company Information
    Table 117. Pfizer, Inc. Description and Major Businesses
    Table 118. Pfizer, Inc. Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 119. Pfizer, Inc. Non-opioid Analgesic Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Pfizer, Inc. Recent Developments
    Table 121. Teikoku Seiyaku Co., Ltd. Company Information
    Table 122. Teikoku Seiyaku Co., Ltd. Description and Major Businesses
    Table 123. Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 124. Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Teikoku Seiyaku Co., Ltd. Recent Developments
    Table 126. Mylan N.V. Company Information
    Table 127. Mylan N.V. Description and Major Businesses
    Table 128. Mylan N.V. Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 129. Mylan N.V. Non-opioid Analgesic Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Mylan N.V. Recent Developments
    Table 131. Hisamitsu Pharmaceutical Co.,Inc Company Information
    Table 132. Hisamitsu Pharmaceutical Co.,Inc Description and Major Businesses
    Table 133. Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 134. Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Hisamitsu Pharmaceutical Co.,Inc Recent Developments
    Table 136. Acorda Therapeutics, Inc Company Information
    Table 137. Acorda Therapeutics, Inc Description and Major Businesses
    Table 138. Acorda Therapeutics, Inc Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 139. Acorda Therapeutics, Inc Non-opioid Analgesic Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Acorda Therapeutics, Inc Recent Developments
    Table 141. Endo International plc Company Information
    Table 142. Endo International plc Description and Major Businesses
    Table 143. Endo International plc Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 144. Endo International plc Non-opioid Analgesic Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Endo International plc Recent Developments
    Table 146. Allergan Company Information
    Table 147. Allergan Description and Major Businesses
    Table 148. Allergan Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 149. Allergan Non-opioid Analgesic Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Allergan Recent Developments
    Table 151. Teh Seng Pharmaceutical Mfg Company Information
    Table 152. Teh Seng Pharmaceutical Mfg Description and Major Businesses
    Table 153. Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 154. Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Teh Seng Pharmaceutical Mfg Recent Developments
    Table 156. IBSA Institut Biochimque SA Company Information
    Table 157. IBSA Institut Biochimque SA Description and Major Businesses
    Table 158. IBSA Institut Biochimque SA Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 159. IBSA Institut Biochimque SA Non-opioid Analgesic Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. IBSA Institut Biochimque SA Recent Developments
    Table 161. Key Raw Materials Lists
    Table 162. Raw Materials Key Suppliers Lists
    Table 163. Non-opioid Analgesic Patch Distributors List
    Table 164. Non-opioid Analgesic Patch Customers List
    Table 165. Non-opioid Analgesic Patch Market Trends
    Table 166. Non-opioid Analgesic Patch Market Drivers
    Table 167. Non-opioid Analgesic Patch Market Challenges
    Table 168. Non-opioid Analgesic Patch Market Restraints
    Table 169. Research Programs/Design for This Report
    Table 170. Key Data Information from Secondary Sources
    Table 171. Key Data Information from Primary Sources
List of Figures
    Figure 1. Non-opioid Analgesic Patch Product Picture
    Figure 2. Global Non-opioid Analgesic Patch Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Non-opioid Analgesic Patch Market Share by Type in 2023 & 2030
    Figure 4. Lidocaine Patches Product Picture
    Figure 5. Diclofenac Patches Product Picture
    Figure 6. Methyl Salicylate Patches Product Picture
    Figure 7. Capsaicin Patches Product Picture
    Figure 8. Ketoprofen Patches Product Picture
    Figure 9. Others Product Picture
    Figure 10. Global Non-opioid Analgesic Patch Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 11. Global Non-opioid Analgesic Patch Market Share by Application in 2023 & 2030
    Figure 12. Hospital Pharmacies
    Figure 13. Online Pharmacies
    Figure 14. Independent Pharmacies & Drug Stores
    Figure 15. Non-opioid Analgesic Patch Report Years Considered
    Figure 16. Global Non-opioid Analgesic Patch Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Non-opioid Analgesic Patch Revenue 2019-2030 (US$ Million)
    Figure 18. Global Non-opioid Analgesic Patch Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 19. Global Non-opioid Analgesic Patch Revenue Market Share by Region (2019-2030)
    Figure 20. Global Non-opioid Analgesic Patch Sales 2019-2030 ((K Units)
    Figure 21. Global Non-opioid Analgesic Patch Sales Market Share by Region (2019-2030)
    Figure 22. US & Canada Non-opioid Analgesic Patch Sales YoY (2019-2030) & (K Units)
    Figure 23. US & Canada Non-opioid Analgesic Patch Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Non-opioid Analgesic Patch Sales YoY (2019-2030) & (K Units)
    Figure 25. Europe Non-opioid Analgesic Patch Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. China Non-opioid Analgesic Patch Sales YoY (2019-2030) & (K Units)
    Figure 27. China Non-opioid Analgesic Patch Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. Asia (excluding China) Non-opioid Analgesic Patch Sales YoY (2019-2030) & (K Units)
    Figure 29. Asia (excluding China) Non-opioid Analgesic Patch Revenue YoY (2019-2030) & (US$ Million)
    Figure 30. Middle East, Africa and Latin America Non-opioid Analgesic Patch Sales YoY (2019-2030) & (K Units)
    Figure 31. Middle East, Africa and Latin America Non-opioid Analgesic Patch Revenue YoY (2019-2030) & (US$ Million)
    Figure 32. The Non-opioid Analgesic Patch Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 33. The Top 5 and 10 Largest Manufacturers of Non-opioid Analgesic Patch in the World: Market Share by Non-opioid Analgesic Patch Revenue in 2023
    Figure 34. Global Non-opioid Analgesic Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 35. Global Non-opioid Analgesic Patch Sales Market Share by Type (2019-2030)
    Figure 36. Global Non-opioid Analgesic Patch Revenue Market Share by Type (2019-2030)
    Figure 37. Global Non-opioid Analgesic Patch Sales Market Share by Application (2019-2030)
    Figure 38. Global Non-opioid Analgesic Patch Revenue Market Share by Application (2019-2030)
    Figure 39. US & Canada Non-opioid Analgesic Patch Sales Market Share by Type (2019-2030)
    Figure 40. US & Canada Non-opioid Analgesic Patch Revenue Market Share by Type (2019-2030)
    Figure 41. US & Canada Non-opioid Analgesic Patch Sales Market Share by Application (2019-2030)
    Figure 42. US & Canada Non-opioid Analgesic Patch Revenue Market Share by Application (2019-2030)
    Figure 43. US & Canada Non-opioid Analgesic Patch Revenue Share by Country (2019-2030)
    Figure 44. US & Canada Non-opioid Analgesic Patch Sales Share by Country (2019-2030)
    Figure 45. U.S. Non-opioid Analgesic Patch Revenue (2019-2030) & (US$ Million)
    Figure 46. Canada Non-opioid Analgesic Patch Revenue (2019-2030) & (US$ Million)
    Figure 47. Europe Non-opioid Analgesic Patch Sales Market Share by Type (2019-2030)
    Figure 48. Europe Non-opioid Analgesic Patch Revenue Market Share by Type (2019-2030)
    Figure 49. Europe Non-opioid Analgesic Patch Sales Market Share by Application (2019-2030)
    Figure 50. Europe Non-opioid Analgesic Patch Revenue Market Share by Application (2019-2030)
    Figure 51. Europe Non-opioid Analgesic Patch Revenue Share by Country (2019-2030)
    Figure 52. Europe Non-opioid Analgesic Patch Sales Share by Country (2019-2030)
    Figure 53. Germany Non-opioid Analgesic Patch Revenue (2019-2030) & (US$ Million)
    Figure 54. France Non-opioid Analgesic Patch Revenue (2019-2030) & (US$ Million)
    Figure 55. U.K. Non-opioid Analgesic Patch Revenue (2019-2030) & (US$ Million)
    Figure 56. Italy Non-opioid Analgesic Patch Revenue (2019-2030) & (US$ Million)
    Figure 57. Russia Non-opioid Analgesic Patch Revenue (2019-2030) & (US$ Million)
    Figure 58. China Non-opioid Analgesic Patch Sales Market Share by Type (2019-2030)
    Figure 59. China Non-opioid Analgesic Patch Revenue Market Share by Type (2019-2030)
    Figure 60. China Non-opioid Analgesic Patch Sales Market Share by Application (2019-2030)
    Figure 61. China Non-opioid Analgesic Patch Revenue Market Share by Application (2019-2030)
    Figure 62. Asia Non-opioid Analgesic Patch Sales Market Share by Type (2019-2030)
    Figure 63. Asia Non-opioid Analgesic Patch Revenue Market Share by Type (2019-2030)
    Figure 64. Asia Non-opioid Analgesic Patch Sales Market Share by Application (2019-2030)
    Figure 65. Asia Non-opioid Analgesic Patch Revenue Market Share by Application (2019-2030)
    Figure 66. Asia Non-opioid Analgesic Patch Revenue Share by Region (2019-2030)
    Figure 67. Asia Non-opioid Analgesic Patch Sales Share by Region (2019-2030)
    Figure 68. Japan Non-opioid Analgesic Patch Revenue (2019-2030) & (US$ Million)
    Figure 69. South Korea Non-opioid Analgesic Patch Revenue (2019-2030) & (US$ Million)
    Figure 70. China Taiwan Non-opioid Analgesic Patch Revenue (2019-2030) & (US$ Million)
    Figure 71. Southeast Asia Non-opioid Analgesic Patch Revenue (2019-2030) & (US$ Million)
    Figure 72. India Non-opioid Analgesic Patch Revenue (2019-2030) & (US$ Million)
    Figure 73. Middle East, Africa and Latin America Non-opioid Analgesic Patch Sales Market Share by Type (2019-2030)
    Figure 74. Middle East, Africa and Latin America Non-opioid Analgesic Patch Revenue Market Share by Type (2019-2030)
    Figure 75. Middle East, Africa and Latin America Non-opioid Analgesic Patch Sales Market Share by Application (2019-2030)
    Figure 76. Middle East, Africa and Latin America Non-opioid Analgesic Patch Revenue Market Share by Application (2019-2030)
    Figure 77. Middle East, Africa and Latin America Non-opioid Analgesic Patch Revenue Share by Country (2019-2030)
    Figure 78. Middle East, Africa and Latin America Non-opioid Analgesic Patch Sales Share by Country (2019-2030)
    Figure 79. Brazil Non-opioid Analgesic Patch Revenue (2019-2030) & (US$ Million)
    Figure 80. Mexico Non-opioid Analgesic Patch Revenue (2019-2030) & (US$ Million)
    Figure 81. Turkey Non-opioid Analgesic Patch Revenue (2019-2030) & (US$ Million)
    Figure 82. Israel Non-opioid Analgesic Patch Revenue (2019-2030) & (US$ Million)
    Figure 83. GCC Countries Non-opioid Analgesic Patch Revenue (2019-2030) & (US$ Million)
    Figure 84. Non-opioid Analgesic Patch Value Chain
    Figure 85. Non-opioid Analgesic Patch Production Process
    Figure 86. Channels of Distribution
    Figure 87. Distributors Profiles
    Figure 88. Bottom-up and Top-down Approaches for This Report
    Figure 89. Data Triangulation
    Figure 90. Key Executives Interviewed